🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and tolerability of dor...
Status
Terminated
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01110408
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of dor...
Status
Terminated
Location
Multiple Locations
Start Date
2010-12
Trial ID
NCT01110421
Treatments Being Tested
The primary objective is to compare the safety and efficacy of cefdinir ora...
Status
Completed
Location
Multiple Locations
Start Date
2003-02
Trial ID
NCT00644943
Treatments Being Tested
The objective of this study is to assess the bioequivalence between Amoxici...
Status
Completed
Location
Pharma Medica Research Inc.
Start Date
2002-08
Trial ID
NCT00840099
The purpose of this study is to test if intravenous sulopenem and an oral d...
Status
Completed
Location
eStudySite, Inc.
Start Date
2009-01
Trial ID
NCT00797108
Treatments Being Tested
The purpose of this study is to assess the bioequivalence between Amoxicill...
Status
Completed
Location
Pharma Medica Research Inc.
Start Date
2002-08
Trial ID
NCT00840840
Treatments Being Tested
This is a phase 2/3, randomized, open-label, active control, multi-center s...
Status
Terminated
Location
Multiple Locations
Start Date
2016-04
Trial ID
NCT02605122
Treatments Being Tested
The objective of this study was to compare the rate and extent of absorptio...
Status
Completed
Location
Anapharm
Start Date
2006-06
Trial ID
NCT00778414
Treatments Being Tested
Augmentin (ES)-600 is a high-dose amoxicillin/clavulanic acid 14:1 formulat...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-05-07
Trial ID
NCT04600752
Treatments Being Tested
The primary focus of the study is the evaluation of the safety of treatment...
Status
Completed
Location
Multiple Locations
Start Date
2010-07-21
Trial ID
NCT01069900